Equity
€401,396 ▲ 23.2%
JAY has made a profit without a break since 2018.
JAY
Lifetime
9 annual accounts with figures on one time axispeak €150,823 (2025)
€150,823▲ 10.6%
lowest -€3,928 (2017)
€92,739▲ 12.8%
peak €401,396 (2025)
€401,396▲ 23.2%
€27,599▼ 59.9%
Board1 name since 2017
1 director
Documentsfilings and deeds
02-04-202628 days before the deadline
2025micro format
Dividend €17,176Equity from €325,833 to €401,396Debts from €68,879 to €27,599Cash from €220,778 to €311,860
Key points
from the 2025 annual accountsChecked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 34,721 companies had the same profile as JAY has now. Each dot stands for 87 companies, two years later.
95.3%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 34,721 companies, not a prediction for JAY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Purpose change · Legal-form change · Resignations & appointments
“Consultancy, onderzoek en begeleiding voor bedrijven actief in de medische sector; Het voeren van een bureau…” (deed in Dutch) · Legal-form conversion: from private limited company (pre-2019) to private limited company · Board composition: (director (not named in the articles)) · General meeting of 06-08-2021 · Gazette deed
Registered office moved within Holsbeek
New registered office: Lindestraat 49, 3220 Holsbeek · Previous registered office: Rotselaarsebaan 26 bus 2, 3220 Holsbeek, België · Gazette deed
Company renamed from MANAGEMENT to JAY
Registered office moved from Leuven to Holsbeek · Capital increase of €17,600 to €18,600 · Capital from €1,000 to €18,600 · General meeting of 24-03-2017 · Gazette deed
First establishment
Management, Lindestraat 49, Holsbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| JAY Holsbeek | €428,995 | €150,823 | 93.6% | - |
| Medisch Kabinet Dr. Verlinden Georgina Ternat | €437,261 | €137,791 | 71.1% | - |
| Dr. Clara Thienpont Zemst | €471,845 | €139,989 | 61.9% | - |
| INVEST LEOPOLD II Molenbeek-Saint-Jean | €414,795 | €154,505 | -16.5% | - |
| Dr BRAGA S Bullange | €452,382 | €144,634 | 87.2% | 0 |
| ZEHRA BOZOK Schaerbeek | €436,196 | €137,586 | 72.7% | - |
| Dr.SOPHIE DECKERS Malle | €417,548 | €138,072 | 82.6% | - |
These companies have the same main activity as JAY: general medical practice (NACE 86210). They are comparable in size and age: total assets between €415,000 and €472,000, founded between 2011 and 2013.
Official details
Source: KBO- Status
- Active since 01-02-2013Normal situation
- Activity
- General medical practiceNACE 86210
- Establishment unit
- 2.217.455.5333220 Holsbeek, since 11-03-2013
- Financial year end
- 30 September
- Peppol
- Reachable
Annual accounts to 30-09-2025
- ≈ €300,000estimated
- €428,995▲ 8.7%
- Filing
- Filed on 02-04-2026, 28 days before the end of the filing period
Insights on JAY
JAY files the micro format. That format states no turnover. The gross margin rose from €2,599 in 2017 to €150,823 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about JAY
- What is the company number of JAY?
- The company number of JAY is 0521.896.721. The VAT number is the same number with BE in front: BE 0521.896.721.
- Where is JAY based?
- The registered office is at Lindestraat 49, 3220 Holsbeek.Company details
- What does JAY do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of JAY?
- JAY is a private limited company (BV).
- When was JAY founded?
- JAY was founded on 01-02-2013.
- Is JAY still active?
- Yes, JAY is an active enterprise in the KBO register.
- What is the turnover of JAY?
- The turnover in financial year 2025 is ≈ €300,000. This figure is estimated from the gross margin of €150,823 and 64 comparable companies (NACE 862). It probably lies between €230,000 and €380,000.Financials
- Is JAY profitable?
- In financial year 2025, JAY made a profit of €92,739.
- Where can I find the annual accounts of JAY?
- JAY filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of JAY due?
- JAY must file the annual accounts for financial year 2026 by 30-04-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.